Bovolenta's lab at the @CBMSO_CSIC_UAM reports that SFRP1 acts as an astrocyte-to-microglia amplifier of neuroinflammation, representing a potential valuable therapeutic target to prevent chronic inflammation in neurodegenerative diseases. @emboreports

embopress.org/doi/full/10.15…